Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00340847 · ClinicalTrials.gov registry record
Construction and Use of Lung Tumor Microarray for the Analysis of Gene Expression in Lung Cancer
A clinical trial, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- 500
- Enrollment target
NCT00340847: Completed study, sponsored by National Cancer Institute (NCI).
NCT00340847 is a clinical trial that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 500 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00340847 has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- 500 participants
- Enrollment target
Study Summary
The proposed research intends to construct a set of tissue microarrays containing different types of normal and lung cancer tissues for the study of genes associated with lung cancer. Thus far we have generated a lung cancer tissue arrayusing paraffin embedded archival tissues from 300 lung turmors tissues and 100 adjacent normal tissues. Four- micrometer thickness sections have been cut from the tissue array and were used to survey gene expression status in arrayed tumors using immunohistochemistry methody. We are currently performing IHC studies ot 1) determine protein expression and its correlation with gene expression patterms ovserved using cDNA arrays. 2) Analyze protein expression in the chromosome remodeling pathyway in non-small cell lung cancer. And 3) determine the association of gene expression with lung tumor stage and clinical outcome. The current protocol is needed to complete the above studies and for the production of neuroendocrine tumors.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2001-08-09 |
| Est. Completion | 2010-05-19 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00340847
The ClinicalTrials.gov registry entry for NCT00340847 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00340847 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00340847 about?
NCT00340847 is a clinical study titled "Construction and Use of Lung Tumor Microarray for the Analysis of Gene Expression in Lung Cancer". The proposed research intends to construct a set of tissue microarrays containing different types of normal and lung cancer tissues for the study of genes associated with lung cancer. Thus far we have generated a lung cancer tissue arrayusing paraffin embedded archival tissues from 300 lung turmors ...
What is the current status of trial NCT00340847?
This trial is currently completed. The enrollment target is 500 participants. The study started on 2001-08-09. Estimated completion is 2010-05-19.
Who is sponsoring clinical trial NCT00340847?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.